drugset / Trial / NCT04576312
Safety of Ascending Doses of Niclosamide (UNI911 INHALATION) in Healthy Volunteers
RandomizedSequentialQuadruple-blindOther
Summary
This is a Phase 1 Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study to Assess the Safety of Ascending Doses of UNI911 INHALATION in Healthy Volunteers in Preparation for Evaluation in Adults with COVID-19
Timeline
- Start
- 2020-06-29
- Primary completion
- 2020-12-04
- Completion
- 2020-12-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Niclosamide | Unknown | 2.5 mg | Inhaled |
| Subject | Niclosamide | Unknown | 3.4 mg | Inhaled |
| Subject | Niclosamide | Unknown | 8.4 mg | Inhaled |
| Subject | Niclosamide | Unknown | 25.2 mg | Inhaled |
| Subject | Niclosamide | Unknown | 50.4 mg | Inhaled |